OG里一篇阅读求助～～～

justgo · 发表于 2011-8-11 18:28:43

og12

Frazier and Mosteller assert that

medical research could be improved by

a move toward larger, simpler clinical

Line trials of medical treatments. Currently,

(5) researchers collect far more background

information on patients than is strictly

required for their trials—substantially more

than hospitals collect—thereby escalating

costs of data collection, storage, and

(10) analysis. Although limiting information

collection could increase the risk that

researchers will overlook facts relevant

to a study, Frazier and Mosteller contend

that such risk, nerver entirely eliminable

(15) from research, would still be small in most

studies. Only in research on entirely new

treatments are new and unexpected variables

likely to arise.

Frazier and Mosteller propose not

(20) only that researchers limit data collection

on individual patients but also that

researchers enroll more patients in clinical

trials, thereby obtaining a more representative

sample of the total population with

(25) the disease under study. Often researchers

restrict study participation to patients

who have no ailments besides those being

studied. A treatment judged successful

under these ideal conditions can then

(30) be evaluated under normal conditions.

Broadening the range of trial participants,

Frazier and Mosteller suggest, would

enable researchers to evaluate a treatment’s

efficacy for diverse patients under

(35) various conditions and to evaluate its

effectiveness for different patient subgroups.

For example, the value of a

treatment for a progressive disease may

vary according to a patient’s stage of

(40) disease. Patients’ ages may also affect

a treatment’s efficacy.

--------------------------------------------------------------------------------
The passage is primarily concerned with

A. identifying two practices in medical research that may affect the accuracy of clinical trials

B. describing aspects of medical research that tend to drive up costs

C. evaluating an analysis of certain shortcomings of current medical research practices

D. describing proposed changes to the ways in which clinical trials are conducted

E. explaining how medical researchers have traditionally conducted clinical trials and how such trials are likely to
change

答案选D。不大明白OG上对E的解释：the passage is not concerned with establishing the likelihood of any changes to the way medical research is conducted. 请问这是什么意思啊？

justgo · 发表于 2011-8-11 20:54:21

自己顶

淡云清风 · 发表于 2011-8-12 21:08:04

the passage is not concerned with establishing the likelihood of any changes to the way medical research is conducted.

意思是：这篇文章不是关注医疗研究方法改变的可能性。

回到E，文章只说了F和M两人对于现行医疗研究办法改进的想法，并没说现行医疗研究办法将会按他两想的这样改。所以E不对，而D对。

justgo · 发表于 2011-8-13 16:03:58

the passage is not concerned with establishing the likelihood of any changes to the way medical research is conducted.

意思是：这篇文章不是关注医疗研究方法改变的可能性。

回到E，文章只说了F和M两人对于现行医疗研究办法改进的想法，并没说现行医疗研究办法将会按他两想的这样改。所以E不对，而D对。

-- by 会员淡云清风 (2011/8/12 21:08:04)

谢谢啦！

OG里一篇阅读求助～～～

所属分类: GMAT考试

正在浏览此版块的会员 ()

浏览过的版块